• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUR1受体与橙皮苷和蒙花苷的相互作用预示了缬草在帕金森病中的可能作用机制。

SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson.

作者信息

Santos Gesivaldo, Giraldez-Alvarez Lisandro Diego, Ávila-Rodriguez Marco, Capani Francisco, Galembeck Eduardo, Neto Aristóteles Gôes, Barreto George E, Andrade Bruno

机构信息

Departamento de Ciências Biológicas, Universidade Estadual do Sudoeste da Bahia Jequié, Brazil.

Programa Nacional de Pós-Doutorado (PNPD-CAPES), Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia Jequié, Brazil.

出版信息

Front Aging Neurosci. 2016 May 2;8:97. doi: 10.3389/fnagi.2016.00097. eCollection 2016.

DOI:10.3389/fnagi.2016.00097
PMID:27199743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4852538/
Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders. A theoretical approach of our previous experiments reporting the cytoprotective effects of the Valeriana officinalis compounds extract for PD is suggested. In addiction to considering the PD as a result of mitochondrial metabolic imbalance and oxidative stress, such as in our previous in vitro model of rotenone, in the present manuscript we added a genomic approach to evaluate the possible underlying mechanisms of the effect of the plant extract. Microarray of substantia nigra (SN) genome obtained from Allen Brain Institute was analyzed using gene set enrichment analysis to build a network of hub genes implicated in PD. Proteins transcribed from hub genes and their ligands selected by search ensemble approach algorithm were subjected to molecular docking studies, as well as 20 ns Molecular Dynamics (MD) using a Molecular Mechanic Poison/Boltzman Surface Area (MMPBSA) protocol. Our results bring a new approach to Valeriana officinalis extract, and suggest that hesperidin, and probably linarin are able to relieve effects of oxidative stress during ATP depletion due to its ability to binding SUR1. In addition, the key role of valerenic acid and apigenin is possibly related to prevent cortical hyperexcitation by inducing neuronal cells from SN to release GABA on brain stem. Thus, under hyperexcitability, oxidative stress, asphyxia and/or ATP depletion, Valeriana officinalis may trigger different mechanisms to provide neuronal cell protection.

摘要

帕金森病(PD)是最常见的神经退行性疾病之一。本文提出了一种理论方法,用于探讨我们之前关于缬草化合物提取物对帕金森病具有细胞保护作用的实验。除了像我们之前在鱼藤酮体外模型中那样,将帕金森病视为线粒体代谢失衡和氧化应激的结果外,在本手稿中,我们还增加了一种基因组学方法,以评估植物提取物作用的潜在机制。使用基因集富集分析对从艾伦脑科学研究所获得的黑质(SN)基因组微阵列进行分析,以构建与帕金森病相关的枢纽基因网络。对枢纽基因转录的蛋白质及其通过搜索集成方法算法选择的配体进行分子对接研究,并使用分子力学泊松/玻尔兹曼表面积(MMPBSA)协议进行20纳秒的分子动力学(MD)模拟。我们的结果为缬草提取物带来了一种新的研究方法,并表明橙皮苷以及可能的蒙花苷能够在ATP耗竭期间减轻氧化应激的影响,因为它们具有结合SUR1的能力。此外,缬草酸和芹菜素的关键作用可能与通过诱导黑质神经元细胞向脑干释放γ-氨基丁酸来预防皮质过度兴奋有关。因此,在过度兴奋、氧化应激、窒息和/或ATP耗竭的情况下,缬草可能触发不同的机制来提供神经元细胞保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/a42106e2d886/fnagi-08-00097-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/4242e7efae10/fnagi-08-00097-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/0430687f8814/fnagi-08-00097-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/f641f93e8af2/fnagi-08-00097-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/128efa0f167e/fnagi-08-00097-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/8fc50368f4fa/fnagi-08-00097-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/e15a5b4c956f/fnagi-08-00097-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/6e2755390a67/fnagi-08-00097-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/fdb07f1e4095/fnagi-08-00097-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/a42106e2d886/fnagi-08-00097-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/4242e7efae10/fnagi-08-00097-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/0430687f8814/fnagi-08-00097-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/f641f93e8af2/fnagi-08-00097-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/128efa0f167e/fnagi-08-00097-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/8fc50368f4fa/fnagi-08-00097-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/e15a5b4c956f/fnagi-08-00097-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/6e2755390a67/fnagi-08-00097-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/fdb07f1e4095/fnagi-08-00097-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d0/4852538/a42106e2d886/fnagi-08-00097-g0009.jpg

相似文献

1
SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson.SUR1受体与橙皮苷和蒙花苷的相互作用预示了缬草在帕金森病中的可能作用机制。
Front Aging Neurosci. 2016 May 2;8:97. doi: 10.3389/fnagi.2016.00097. eCollection 2016.
2
Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease.缬草提取物对帕金森病体外实验模型的细胞保护作用。
Neurochem Res. 2009 Feb;34(2):215-20. doi: 10.1007/s11064-008-9749-y. Epub 2008 May 30.
3
Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis.从缬草中分离出的黄酮类化合物香叶木素的镇静和助眠特性。
Pharmacol Biochem Behav. 2004 Feb;77(2):399-404. doi: 10.1016/j.pbb.2003.12.003.
4
Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster.缬草减轻果蝇中鱼藤酮诱导的毒性。
Neurotoxicology. 2013 Jul;37:118-26. doi: 10.1016/j.neuro.2013.04.006. Epub 2013 Apr 29.
5
Counteracts Rotenone Effects on Spreading Depression in the Rat Brain and Protects Against Rotenone Cytotoxicity Toward Rat Glioma C6 Cells .对抗鱼藤酮对大鼠脑皮层扩散性抑制的影响,并保护大鼠胶质瘤C6细胞免受鱼藤酮的细胞毒性作用。
Front Neurosci. 2020 Jul 23;14:759. doi: 10.3389/fnins.2020.00759. eCollection 2020.
6
Antioxidant effect and study of bioactive components of Valeriana sisymbriifolia and Nardostachys jatamansii in comparison to Valeriana officinalis.缬草、匙叶甘松和甘松与药用缬草相比的抗氧化作用及生物活性成分研究
Pak J Pharm Sci. 2013 Jan;26(1):53-8.
7
Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier.缬草属广义植物中一种γ-氨基丁酸A型受体调节剂及其衍生物透过血脑屏障体外细胞培养模型的转运
Planta Med. 2008 Sep;74(11):1338-44. doi: 10.1055/s-2008-1081343. Epub 2008 Aug 14.
8
In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain.缬草提取物及其氨基酸与大鼠脑内GABAA受体相互作用的体外研究。
Arzneimittelforschung. 1995 Jul;45(7):753-5.
9
Identification of key genes associated with secondary metabolites biosynthesis by system network analysis in Valeriana officinalis.基于系统网络分析鉴定缬草中与次生代谢产物生物合成相关的关键基因。
J Plant Res. 2021 May;134(3):625-639. doi: 10.1007/s10265-021-01277-5. Epub 2021 Apr 7.
10
Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia.缬草标准化提取物对失眠患者催眠作用的多导睡眠图评估。
Planta Med. 2001 Nov;67(8):695-9. doi: 10.1055/s-2001-18344.

引用本文的文献

1
Natural flavonoids as potential therapeutics in the management of Alzheimer's disease: a review.天然黄酮类化合物作为阿尔茨海默病治疗的潜在疗法:综述
3 Biotech. 2024 Mar;14(3):68. doi: 10.1007/s13205-024-03925-8. Epub 2024 Feb 13.
2
Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action.黄酮类化合物的神经保护潜力:实验研究与作用机制
Antioxidants (Basel). 2023 Jan 27;12(2):280. doi: 10.3390/antiox12020280.
3
Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer's Disease.天然化合物和靶酶在阿尔茨海默病治疗中的作用。

本文引用的文献

1
Putamen-midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases.壳核-中脑功能连接与路易体病患者纹状体多巴胺转运体可用性相关。
Neuroimage Clin. 2015 Jun 9;8:554-9. doi: 10.1016/j.nicl.2015.06.001. eCollection 2015.
2
Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.小鼠中用6-羟基多巴胺逐渐耗竭多巴胺过程中运动功能障碍的差异性降解。
Neuroscience. 2015 Aug 20;301:254-67. doi: 10.1016/j.neuroscience.2015.05.068. Epub 2015 Jun 9.
3
Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
Molecules. 2022 Jun 29;27(13):4175. doi: 10.3390/molecules27134175.
4
Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis.注意力缺陷多动障碍(ADHD)的植物疗法:系统评价与荟萃分析
Front Pharmacol. 2022 May 3;13:827411. doi: 10.3389/fphar.2022.827411. eCollection 2022.
5
Linarin, a Glycosylated Flavonoid, with Potential Therapeutic Attributes: A Comprehensive Review.木犀草苷,一种糖基化黄酮类化合物,具有潜在治疗特性:综述
Pharmaceuticals (Basel). 2021 Oct 29;14(11):1104. doi: 10.3390/ph14111104.
6
Cytotoxicity and Oxidative Stress Evaluation of Valerian Methanolic Extract in Hepg2 and Caco2 Cells.缬草甲醇提取物对Hepg2和Caco2细胞的细胞毒性及氧化应激评估
Turk J Pharm Sci. 2021 Oct 28;18(5):604-608. doi: 10.4274/tjps.galenos.2021.04903.
7
Ameliorative Effects of the Sesquiterpenoid Valerenic Acid on Oxidative Stress Induced in HepG2 Cells after Exposure to the Fungicide Benomyl.倍半萜类缬草烯酸对接触杀菌剂苯菌灵后HepG2细胞诱导的氧化应激的改善作用
Antioxidants (Basel). 2021 May 8;10(5):746. doi: 10.3390/antiox10050746.
8
Plant Species of Sub-Family Valerianaceae-A Review on Its Effect on the Central Nervous System.缬草亚科植物物种——关于其对中枢神经系统影响的综述
Plants (Basel). 2021 Apr 22;10(5):846. doi: 10.3390/plants10050846.
9
Anti-Parkinson's Activity of via Modulation of AChE, α-Synuclein, TNF-α, and IL-1β.通过调节乙酰胆碱酯酶、α-突触核蛋白、肿瘤坏死因子-α和白细胞介素-1β发挥抗帕金森病活性
ACS Omega. 2020 Sep 22;5(39):25216-25227. doi: 10.1021/acsomega.0c03375. eCollection 2020 Oct 6.
10
Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics.天然化合物对神经退行性疾病的影响:从临床前研究到药物治疗
J Clin Med. 2020 Apr 8;9(4):1061. doi: 10.3390/jcm9041061.
为什么田本系数是基于指纹的相似性计算的合适选择?
J Cheminform. 2015 May 20;7:20. doi: 10.1186/s13321-015-0069-3. eCollection 2015.
4
An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions.帕金森病鱼藤酮模型的最新进展:其再现临床疾病特征及模拟基因-环境相互作用的能力。
Neurotoxicology. 2015 Jan;46:101-16. doi: 10.1016/j.neuro.2014.12.002. Epub 2014 Dec 13.
5
Isoflavones with neuroprotective activities from fruits of Cudrania tricuspidata.来自柘树果实的具有神经保护活性的异黄酮。
Phytochemistry. 2015 Mar;111:141-8. doi: 10.1016/j.phytochem.2014.10.021. Epub 2014 Dec 6.
6
Neuroprotective effect of modified Chungsimyeolda-tang, a traditional Korean herbal formula, via autophagy induction in models of Parkinson's disease.通过自噬诱导,改良的传统韩国草药方剂——仲景四逆汤对帕金森病模型的神经保护作用。
J Ethnopharmacol. 2015 Jan 15;159:93-101. doi: 10.1016/j.jep.2014.11.007. Epub 2014 Nov 13.
7
Are sleep disturbances preclinical markers of Parkinson's disease?睡眠障碍是帕金森病的临床前标志物吗?
Neurochem Res. 2015 Mar;40(3):421-7. doi: 10.1007/s11064-014-1488-7. Epub 2014 Nov 30.
8
Treatment of sleeping disorders should be considered in clinical management of Parkinson's disease.帕金森病的临床管理中应考虑睡眠障碍的治疗。
Front Aging Neurosci. 2014 Oct 9;6:273. doi: 10.3389/fnagi.2014.00273. eCollection 2014.
9
Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.星形胶质细胞对血脑屏障的调节:帕金森病的研究视角。
Front Cell Neurosci. 2014 Aug 4;8:211. doi: 10.3389/fncel.2014.00211. eCollection 2014.
10
Neuroprotective Xanthones from the Root Bark of Cudrania tricuspidata.三齿乌蔹莓根皮中的神经保护黄烷酮。
J Nat Prod. 2014 Aug 22;77(8):1893-901. doi: 10.1021/np500364x.